NCT05439941: A reported trial by Evelo Biosciences, Inc.
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT05439941 |
|---|---|
| Title | A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous Phase 2 And 3 EDP1815 Trials |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 6, 2022 |
| Completion date | May 25, 2023 |
| Required reporting date | May 24, 2024, midnight |
| Actual reporting date | July 14, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |